Abiraterone + prednisone

DRUG2 trials

Sponsors

University Health Network, Toronto, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions

Castration-resistant Prostate CancermCRPC

Phase 2

Biomarkers of Androgen Response and Resistance In Evolution During a Rising PSA

CompletedNCT02429193

University Health Network, TorontoCastration-resistant Prostate Cancer

Start: 2016-03-31End: 2019-09-01Target: 16Updated: 2020-01-13

Efficacy and Safety of Disitamab Vedotin Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer：a Phase II Study

RecruitingNCT07093866

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolmCRPC

Start: 2025-07-20End: 2027-12-30Target: 20Updated: 2025-07-30